M. Alter, Epidemiology of viral hepatitis and HIV co-infection, Journal of Hepatology, vol.44, issue.1, pp.6-9, 2006.
DOI : 10.1016/j.jhep.2005.11.004

K. Sherman, S. Rouster, and R. Chung, Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group, Clinical Infectious Diseases, vol.34, issue.6, pp.831-837, 2002.
DOI : 10.1086/339042

C. Graham, L. Baden, and E. Yu, Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta???Analysis, Clinical Infectious Diseases, vol.33, issue.4, pp.562-569, 2001.
DOI : 10.1086/321909

C. Martinez-sierra, A. Arizcorreta, and F. Diaz, Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus, Clinical Infectious Diseases, vol.36, issue.4, pp.491-498, 2003.
DOI : 10.1086/367643

L. Martin-carbonero, Y. Benhamou, and M. Puoti, Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus???Infected Patients with Chronic Hepatitis C: A European Collaborative Study, Clinical Infectious Diseases, vol.38, issue.1, pp.128-133, 2004.
DOI : 10.1086/380130

A. Mohsen, P. Easterbrook, and C. Taylor, Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients, Gut, vol.52, issue.7, pp.1035-1040, 2003.
DOI : 10.1136/gut.52.7.1035

D. Salmon-ceron, C. Lewden, and P. Morlat, Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol, Journal of Hepatology, vol.42, issue.6, pp.799-805, 2005.
DOI : 10.1016/j.jhep.2005.01.022

R. Chung, J. Andersen, and P. Volberding, Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Persons, New England Journal of Medicine, vol.351, issue.5, pp.451-459, 2004.
DOI : 10.1056/NEJMoa032653

F. Carrat, F. Bani-sadr, and S. Pol, Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>, JAMA, vol.292, issue.23, pp.2839-2848, 2004.
DOI : 10.1001/jama.292.23.2839

F. Torriani, M. Rodriguez-torres, and J. Rockstroh, Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients, New England Journal of Medicine, vol.351, issue.5, pp.438-450, 2004.
DOI : 10.1056/NEJMoa040842

A. Bravo, S. Sheth, and S. C. , Liver Biopsy, New England Journal of Medicine, vol.344, issue.7, pp.495-500, 2001.
DOI : 10.1056/NEJM200102153440706

L. Castéra, I. Nègre, and K. Samii, Pain experienced during percutaneous liver biopsy, Hepatology, vol.352, issue.Suppl, pp.1529-1530, 1999.
DOI : 10.1002/hep.510300624

J. Cadranel, P. Rufat, and F. D. , Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey, Hepatology, vol.34, issue.3, pp.477-481, 2000.
DOI : 10.1053/jhep.2000.16602

P. Bedossa, D. Dargère, and V. Paradis, Sampling variability of liver fibrosis in chronic hepatitis C, Hepatology, vol.36, issue.6, pp.1449-1457, 2003.
DOI : 10.1016/j.hep.2003.09.022

G. Colloredo, M. Guido, and A. Sonzogni, Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease, Journal of Hepatology, vol.39, issue.2, pp.239-244, 2003.
DOI : 10.1016/S0168-8278(03)00191-0

A. Regev, M. Berho, and L. Jeffers, Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection, The American Journal of Gastroenterology, vol.68, issue.10, pp.2614-2618, 2002.
DOI : 10.1016/S0168-8278(96)80234-0

C. Wai, J. Greenson, and R. Fontana, A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C, Hepatology, vol.4, issue.2, pp.518-526, 2003.
DOI : 10.1053/jhep.2003.50346

X. Forns, S. Ampurdanes, and J. Llovet, Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model, Hepatology, vol.42, issue.4, pp.986-992, 2002.
DOI : 10.1053/jhep.2002.36128

C. Lackner, G. Struber, and B. Liegl, Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C, Hepatology, vol.36, issue.6, pp.1376-1382, 2005.
DOI : 10.1002/hep.20717

R. Sterling, E. Lissen, and N. Clumeck, Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection, Hepatology, vol.41, issue.6, pp.1317-1325, 2006.
DOI : 10.1002/hep.21178

A. Vallet-pichard, V. Mallet, and B. Nalpas, FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest, Hepatology, vol.13, issue.1, pp.32-38, 2007.
DOI : 10.1002/hep.21669

C. Binquet, G. Chene, and H. Jacqmin-gadda, Modeling Changes in CD4-positive T-Lymphocyte Counts after the Start of Highly Active Antiretroviral Therapy and the Relation with Risk of Opportunistic Infections The Aquitaine Cohort, 1996???1997, American Journal of Epidemiology, vol.153, issue.4, pp.386-393, 1996.
DOI : 10.1093/aje/153.4.386

J. Hanley and B. Mcneil, A method of comparing the areas under receiver operating characteristic curves derived from the same cases., Radiology, vol.148, issue.3, pp.839-882, 1983.
DOI : 10.1148/radiology.148.3.6878708

N. Afdhal and D. N. , Evaluation of Liver Fibrosis: A Concise Review, The American Journal of Gastroenterology, vol.12, issue.6, pp.1160-1174, 2004.
DOI : 10.1016/S0168-8278(00)80079-3

L. Castera, J. Denis, and G. Babany, Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines?, Journal of Hepatology, vol.46, issue.3, pp.528-529, 2007.
DOI : 10.1016/j.jhep.2006.12.002

F. Imbert-bismut, V. Ratziu, and L. Pieroni, Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, The Lancet, vol.357, issue.9262, pp.1069-1075, 2001.
DOI : 10.1016/S0140-6736(00)04258-6

R. Myers, Y. Benhamou, and F. Imbert-bismut, Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients, AIDS, vol.17, issue.5, pp.721-725, 2003.
DOI : 10.1097/00002030-200303280-00010

T. Kelleher, S. Mehtaa, and R. Bhaskarb, Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: The SHASTA index, Journal of Hepatology, vol.43, issue.1, pp.78-84, 2005.
DOI : 10.1016/j.jhep.2005.02.025

V. Leroy, M. Hilleret, and N. Sturm, Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C, Journal of Hepatology, vol.46, issue.5, pp.775-782, 2007.
DOI : 10.1016/j.jhep.2006.12.013
URL : https://hal.archives-ouvertes.fr/inserm-00324953

L. Castera, J. Vergniol, and J. Foucher, Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C, Gastroenterology, vol.128, issue.2, pp.343-350, 2005.
DOI : 10.1053/j.gastro.2004.11.018

J. Macias, J. Giron-gonzalez, and M. Gonzalez-serrano, Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes, Gut, vol.55, issue.3, pp.310-312, 2006.
DOI : 10.1136/gut.2005.065904

J. Cole, U. Marzec, and C. Gunthel, Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients, Blood, vol.91, pp.3239-3246, 1998.

N. Kontorinis and D. D. , Hepatotoxicity of antiretroviral therapy, AIDS Rev, vol.5, pp.36-43, 2003.

M. Bonacini, Liver Injury during Highly Active Antiretroviral Therapy: The Effect of Hepatitis C Coinfection, Clinical Infectious Diseases, vol.38, issue.Supplement 2, pp.104-108, 2004.
DOI : 10.1086/381453

G. Sebastiani, A. Vario, and M. Guido, Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C, Journal of Hepatology, vol.44, issue.4, pp.686-693, 2006.
DOI : 10.1016/j.jhep.2006.01.007